Consort Medical gets US thumbs up
Consort Medical said the first product to use its built-in dose counter had been given the go-ahead by the US Food and Drug Administration.
Consort Medical said the first product to use its built-in dose counter had been given the go-ahead by the US Food and Drug Administration.
Consort's Integrated Dose Counter (IDC) is being used in Teva's QNASL nasal aerosol, which treats of nasal seasonal allergy symptoms.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
It provides patients with an indication of how many doses are left inside the canister in line with FDA guidance.
"We are very pleased to announce that the FDA has approved the use of our IDC with Teva's QNASL, making this our first commercially marketed integrated dose counter," said chief executive Jon Glenn.
-
Will fintechs change the way you invest?: MoneyWeek TalksPodcast MoneyWeek's digital editor, Kalpana Fitzpatrick, speaks to Revolut Trading CEO Yana Shkrebenkova about how fintechs are changing the way people approach investing.
-
Six steps business owners should consider before April inheritance tax relief changeNew limits to inheritance tax-free allowances are coming in from the Spring that affect business owners. Those looking to sell or transfer their assets into a trust before the changes need to act now
